Scleroderma Research Foundation has awarded $16 million across 124 grants to 28 organizations between 2020 and 2025. Its giving concentrates in education. Its typical grant is $84,723, with most between $26,816 and $147,103.
Each grantee's funding from this organization, summed across all reported years. Largest first — click any column to re-sort.
| Grantee | Total received | Grants | Years | Latest | State | Follow |
|---|---|---|---|---|---|---|
|
|
$3.5M | 6 | 2020–2025 | 2025 | CA | |
|
|
$1.6M | 6 | 2020–2025 | 2025 | MD | |
| U University of Utah | $1.6M | 6 | 2020–2025 | 2025 | UT | |
| U Univ of Tx Health Science Ctr | $1.3M | 9 | 2020–2025 | 2025 | — | — |
|
|
$952K | 6 | 2020–2025 | 2025 | NY | |
| R Regents of the University of Michigan | $903K | 5 | 2021–2025 | 2025 | MI | |
|
|
$804K | 6 | 2020–2025 | 2025 | PA | |
|
|
$755K | 6 | 2020–2025 | 2025 | CT | |
| R Regents of Univ of Ca-Ucsf | $728K | 6 | 2020–2025 | 2025 | CA | — |
|
|
$382K | 3 | 2023–2025 | 2025 | NH | |
|
|
$374K | 4 | 2022–2025 | 2025 | TN | |
| 1 1982 Dartmouth College Clas of | $346K | 3 | 2020–2022 | 2022 | CO | |
|
|
$344K | 4 | 2022–2025 | 2025 | MA | |
|
|
$290K | 6 | 2020–2025 | 2025 | NY | |
| N NYU Grossman School Medicine | $250K | 2 | 2023–2025 | 2025 | — | — |
| R Regents Univ of California | $244K | 3 | 2023–2025 | 2025 | CA | |
|
|
$231K | 6 | 2020–2025 | 2025 | PA | |
|
|
$224K | 6 | 2020–2025 | 2025 | IL | |
|
|
$172K | 6 | 2020–2025 | 2025 | DC | |
|
|
$169K | 2 | 2020–2021 | 2021 | NY | |
|
|
$168K | 4 | 2022–2025 | 2025 | NC | |
| U USC | $150K | 2 | 2024–2025 | 2025 | CA | — |
|
|
$110K | 1 | 2025 | 2025 | — | |
| M Massachusetts Generalhospital | $86K | 4 | 2021–2025 | 2025 | MA | — |
|
|
$72K | 4 | 2022–2025 | 2025 | MN | |
|
|
$46K | 5 | 2021–2025 | 2025 | SC | |
| U University of Colorado Health | $32K | 1 | 2025 | 2025 | — | |
| R Regents of the Univ Minnesota | $30K | 2 | 2024–2025 | 2025 | — | — |
Leave your email and we’ll let you know when you can finish signing in and follow the organization.
Try signing in anyway →